AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAYNE PHARMA GROUP LTD

2.280

-0.010-0.44%

Volume:269.09K

Turnover:616.72K

Market Cap:185.24M

PE:-2.17

High:2.330

Open:2.280

Low:2.230

Close:2.290

52wk High:7.280

52wk Low:2.040

Shares:81.25M

Float Shares:67.00M

Volume Ratio:0.26

T/O Rate:0.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.051

EPS(LYR):-1.186

ROE:-20.58%

ROA:-2.30%

PB:0.53

PE(LYR):-1.92

Loading ...

Overview Company News Filings

Mayne Pharma - Grounds Set Out in Notice of Appeal Seek to Challenge Court's Findings Regarding Co's FY25 Ebitda, Others

THOMSON REUTERS

Mayne Pharma Group Ltd - Considering Notice of Appeal and Intends to Vigorously Defend Appeal

THOMSON REUTERS

BUZZ-Australia's Mayne Pharma hits over 2-year low on board resizing

BRIEF-Mayne Pharma Says Board Chair Frank Condella Has Decided To Retire

ASX Preview: Australian Shares Set to Fall Amid Oil Surge; BlueScope Steel to Pay Special Dividend

MT Newswires Live

Mayne Pharma Group Chair to Retire

MT Newswires Live

Mayne Pharma Group Ltd - Bruce Robinson Has Been Appointed as Non-Executive Chair of Board

THOMSON REUTERS

Mayne Pharma Group Ltd-Change of Director's Interest Notice

THOMSON REUTERS

Mayne Pharma Group Says Net Revenues Fall 5.5% Year on Year for the Period Between July, November

MT Newswires Live

BRIEF-Mayne Pharma Says Net Revenues Were A$165 Million For First 5 Months Of FY26

Mayne Pharma Group - Net Revenues Were a$165 Mln for First 5 Months of FY26

THOMSON REUTERS

Mayne Pharma Group - Underlying Ebitda for First 5 Months of FY26 Was a$11.5M

THOMSON REUTERS

Mayne Pharma Opens New Manufacturing Facility in South Australia

MT Newswires Live

Mayne Pharma Group Ltd - Official Inauguration of Expanded Manufacturing Facility Located in Salisbury, South Australia.

THOMSON REUTERS

Termination of Proposed Acquisition of Mayne Pharma

THOMSON REUTERS

BRIEF-Mayne Pharma Terminates Scheme Implementation Deed With Cosette

Mayne Pharma Group Provides Cosette With Scheme Implementation Deed Termination Notice

MT Newswires Live

Mayne Pharma Group Ltd - Provided Cosette With Notice to Terminate Scheme Implementation Deed

THOMSON REUTERS

Mayne Pharma Group Ltd - to Enforce Costs Order Against Cosette on 16 October

THOMSON REUTERS

BRIEF-Mayne Pharma Receives Purported Termination Notice From Cosette

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MYX.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":2.28,"timestamp":1774588320000,"preClose":2.29,"halted":0,"volume":269086,"delay":0,"changeRate":-0.004366812227074336,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.051059,"marketStatus":"Market Closed","change":-0.01,"latestTime":"03-27 16:12:00 AEDT","open":2.28,"high":2.33,"low":2.23,"amount":616717,"amplitude":0.043668,"askPrice":2.31,"askSize":6096,"bidPrice":2.27,"bidSize":3570,"shortable":3,"etf":0,"ttmEps":-1.051059,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":2.29,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":0.26255801991924094,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MYX.AU","preClose":2.29,"auctionPrice":2.28,"auctionVolume":16071,"auction":3,"marketStatus":"盘后竞价","timestamp":1774588210937}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-2.30%","roe":"-20.58%","lyrEps":-1.185711,"volumeRatio":0.26255801991924094,"shares":81245827,"dividePrice":0,"high":2.33,"amplitude":0.043668,"preClose":2.29,"low":2.23,"week52Low":2.04,"pbRate":"0.53","psRate":"0.46","week52High":7.28,"institutionHeld":0,"latestPrice":2.28,"committee":-0.261328,"eps":-1.051059,"divideRate":0,"volume":269086,"delay":0,"ttmEps":-1.051059,"open":2.28,"prevYearClose":3.11,"prevWeekClose":2.2,"prevMonthClose":2.52,"prevQuarterClose":3.11,"fiveDayClose":2.2,"twentyDayClose":2.52,"sixtyDayClose":3.11,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null},{"date":"2024-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708902000000,"name":null,"time":"","dateTimestamp":1708866000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603678611","title":"Mayne Pharma - Grounds Set Out in Notice of Appeal Seek to Challenge Court's Findings Regarding Co's FY25 Ebitda, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2603678611","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603678611?lang=en_us&edition=fundamental","pubTime":"2026-01-15 12:55","pubTimestamp":1768452936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF21V:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2603618678","title":"Mayne Pharma Group Ltd - Considering Notice of Appeal and Intends to Vigorously Defend Appeal","url":"https://stock-news.laohu8.com/highlight/detail?id=2603618678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603618678?lang=en_us&edition=fundamental","pubTime":"2026-01-15 12:55","pubTimestamp":1768452936,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nFWN3YF21V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2603113650","title":"BUZZ-Australia's Mayne Pharma hits over 2-year low on board resizing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603113650","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603113650?lang=en_us&edition=fundamental","pubTime":"2026-01-14 10:34","pubTimestamp":1768358052,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mayne Pharma hits over 2-year low on board resizing** Shares of Mayne Pharma MYX.AX slip 1.66% to A$2.96, their lowest since mid-October 2023** Pharma co to cut board's size, says mov","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nL6N3YF05X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"2603652142","title":"BRIEF-Mayne Pharma Says Board Chair Frank Condella Has Decided To Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2603652142","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603652142?lang=en_us&edition=fundamental","pubTime":"2026-01-14 09:38","pubTimestamp":1768354689,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Says Board Chair Frank Condella Has Decided To RetireJan 14  - Mayne Pharma Group Ltd MYX.AX:MAYNE PHARMA BOARD CHANGESFRANK CONDELLA, BOARD CHAIR, HAS DECIDED TO RETIREBRUCE ROBINSON HAS BEEN APPOINTED AS NON-EXECUTIVE CHAIR OF BOARDFurther company coverage: MYX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nTUEB675D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2603807656","title":"ASX Preview: Australian Shares Set to Fall Amid Oil Surge; BlueScope Steel to Pay Special Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2603807656","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603807656?lang=en_us&edition=fundamental","pubTime":"2026-01-14 07:02","pubTimestamp":1768345321,"startTime":"0","endTime":"0","summary":"Australian shares are poised to fall on Wednesday as surging global oil prices, driven by unrest in Iran and supply uncertainties from Venezuela, heighten investor concerns over energy costs and marke","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","BK7508","BSL.AU","BK7096","MYX.AU","XAO.AU","BK7129","XKO.AU"],"gpt_icon":0},{"id":"2603556716","title":"Mayne Pharma Group Chair to Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2603556716","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603556716?lang=en_us&edition=fundamental","pubTime":"2026-01-14 06:35","pubTimestamp":1768343739,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group (ASX:MYX) said that Chair Frank Condella has decided to retire from the board, effective Wednesday, according to a same-day Australian bourse filing.Bruce Robinson has been appointed non-executive chair, effective Wednesday, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2603535196","title":"Mayne Pharma Group Ltd - Bruce Robinson Has Been Appointed as Non-Executive Chair of Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2603535196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603535196?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:53","pubTimestamp":1768341211,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUEB675D2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2593468021","title":"Mayne Pharma Group Ltd-Change of Director's Interest Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2593468021","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593468021?lang=en_us&edition=fundamental","pubTime":"2025-12-23 11:23","pubTimestamp":1766460228,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nTUE24F4VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2593177775","title":"Mayne Pharma Group Says Net Revenues Fall 5.5% Year on Year  for the Period Between July, November","url":"https://stock-news.laohu8.com/highlight/detail?id=2593177775","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593177775?lang=en_us&edition=fundamental","pubTime":"2025-12-22 10:35","pubTimestamp":1766370944,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said that during the period from July to November, its net revenues were AU$165 million, falling 5.5% from the same period in the previous year, according to a Monday Australian bourse filing.The Women's Health sector was flat at $50.8 million while dermatology was down 12% to $37.1 million over the same period. The Women's Health sector saw continued growth with demand for total prescriptions showing continued volume growth through the first five months of fiscal year 2026.Underlying earnings before interest, taxes, depreciation, and amortization for the period was AU$11.5 million compared to the prior-year EBITDA of AU$22.4 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2593171449","title":"BRIEF-Mayne Pharma Says Net Revenues Were A$165 Million For First 5 Months Of FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2593171449","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593171449?lang=en_us&edition=fundamental","pubTime":"2025-12-22 08:58","pubTimestamp":1766365085,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Says Net Revenues Were A$165 Million For First 5 Months Of FY26Dec 22  - Mayne Pharma Group Ltd MYX.AX:UNDERLYING EBITDA FOR FIRST 5 MONTHS OF FY26 WAS A$11.5MNET REVENUES WERE A$165 MILLION FOR FIRST 5 MONTHS OF FY26Further company coverage: MYX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XR02U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2593756291","title":"Mayne Pharma Group -  Net Revenues Were a$165 Mln for First 5 Months of FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2593756291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593756291?lang=en_us&edition=fundamental","pubTime":"2025-12-22 05:44","pubTimestamp":1766353491,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251221:nFWN3XR02U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2593175621","title":"Mayne Pharma Group - Underlying Ebitda for First 5 Months of FY26 Was a$11.5M","url":"https://stock-news.laohu8.com/highlight/detail?id=2593175621","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593175621?lang=en_us&edition=fundamental","pubTime":"2025-12-22 05:44","pubTimestamp":1766353491,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251221:nFWN3XR02U:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"2591594603","title":"Mayne Pharma Opens New Manufacturing Facility in South Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2591594603","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591594603?lang=en_us&edition=fundamental","pubTime":"2025-12-16 14:01","pubTimestamp":1765864860,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said it has opened an expanded manufacturing facility located in Salisbury, South Australia, according to a Tuesday Australian bourse filing.The facility occupies a 12-hectare site and is designed for large-scale production of solid oral and topical dosage forms, including tablets, capsules, powders, pellets, liquids, and creams.The company added that it has invested about AU$18 million over the past two years to modernize and expand this plant by adding a new highspeed encapsulation suite and other automation upgrades.The completion of the upgraded facility expands the manufacturing capacity and capability, which includes serialisation capability, to support new product launches and exports from the site, the filing added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","BK7508","MYX.AU","BK7096","XAO.AU","XKO.AU"],"gpt_icon":0},{"id":"2591885674","title":"Mayne Pharma Group Ltd -  Official Inauguration of Expanded Manufacturing Facility Located in Salisbury, South Australia.","url":"https://stock-news.laohu8.com/highlight/detail?id=2591885674","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591885674?lang=en_us&edition=fundamental","pubTime":"2025-12-16 10:41","pubTimestamp":1765852897,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XL118:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"2590107542","title":"Termination of Proposed Acquisition of Mayne Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590107542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590107542?lang=en_us&edition=fundamental","pubTime":"2025-12-12 06:57","pubTimestamp":1765493832,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XH16U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2590055792","title":"BRIEF-Mayne Pharma Terminates Scheme Implementation Deed With Cosette","url":"https://stock-news.laohu8.com/highlight/detail?id=2590055792","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590055792?lang=en_us&edition=fundamental","pubTime":"2025-12-11 09:24","pubTimestamp":1765416284,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Terminates Scheme Implementation Deed With CosetteDec 11  - Mayne Pharma Group Ltd MYX.AX:MAYNE PHARMA TERMINATES SCHEME IMPLEMENTATION DEED-MYX.AXPROVIDED COSETTE WITH NOTICE TO TERMINATE SCHEME IMPLEMENTATION DEEDTO ENFORCE COSTS ORDER AGAINST COSETTE ON 16 OCTOBERFurther company coverage: MYX.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XG19X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"2590551973","title":"Mayne Pharma Group Provides Cosette With Scheme Implementation Deed Termination Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2590551973","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590551973?lang=en_us&edition=fundamental","pubTime":"2025-12-11 08:02","pubTimestamp":1765411361,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group  said it provided Cosette Pharmaceuticals with a notice of termination of the scheme implementation deed  for the proposed acquisition of the company by Cosette because the scheme was not implemented, according to a Thursday filing with the Australian bourse.The termination releases Mayne from the restrictions imposed on it under the terms of the scheme and does not give rise to any obligation for the company to pay the break fee, the filing said.The company said it plans to enforce the costs order made against Cosette in October.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","BK4006","MYX.AU","BK7508","SID"],"gpt_icon":0},{"id":"2590556446","title":"Mayne Pharma Group Ltd - Provided Cosette With Notice to Terminate Scheme Implementation Deed","url":"https://stock-news.laohu8.com/highlight/detail?id=2590556446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590556446?lang=en_us&edition=fundamental","pubTime":"2025-12-11 06:40","pubTimestamp":1765406458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG19X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0},{"id":"2590556440","title":"Mayne Pharma Group Ltd - to Enforce Costs Order Against Cosette on 16 October","url":"https://stock-news.laohu8.com/highlight/detail?id=2590556440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590556440?lang=en_us&edition=fundamental","pubTime":"2025-12-11 06:40","pubTimestamp":1765406458,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG19X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2590312376","title":"BRIEF-Mayne Pharma Receives Purported Termination Notice From Cosette","url":"https://stock-news.laohu8.com/highlight/detail?id=2590312376","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590312376?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:21","pubTimestamp":1765329707,"startTime":"0","endTime":"0","summary":"BRIEF-Mayne Pharma Receives Purported Termination Notice From CosetteDec 10 (Reuters) - Mayne Pharma Group Ltd MYX.AX:MYX RECEIVES PURPORTED TERMINATION NOTICE FROM COSETTEREJECTS COSETTE TERMINATION NOTICE AS INVALIDFurther company coverage: MYX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XF0J0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","MYX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":120,"code":"91000000","status":"200"}]}}